Response to PD-1-Based Immunotherapy for Non-Small Cell Lung Cancer Altered by Gut Microbiota

INTRODUCTION: This study was designed to identify a group of bacteria in the human gut microbiota with specific effects on PD-1-based immunotherapy for patients with non-small cell lung cancer (NSCLC). METHODS: The study was performed in patients with advanced NSCLC, who received PD-1 monoclonal ant...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Daqiang, Li, Xing, An, Rui, Wang, Lihong, Wang, Yun, Zheng, Song, Chen, Xueqing, Wang, Xianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593091/
https://www.ncbi.nlm.nih.gov/pubmed/34664203
http://dx.doi.org/10.1007/s40487-021-00171-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593091/
https://www.ncbi.nlm.nih.gov/pubmed/34664203
http://dx.doi.org/10.1007/s40487-021-00171-3

Ejemplares similares